{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T15:58:05Z","timestamp":1697990285822},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":8264,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1985,8]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The effects of oestrogen priming on the response of serum PRL, LH and TSH to dopamine (DA) infusion have been studied in hyperprolactinaemia. Seven hyperprolactinaemic females (aged 22\u201357 years; basal PRL 911\u20135130 mU\/1, normal &gt;420 mU\/1), had submaximal DA infusions (0\u00b706 \u03bcg\/kg\/min) over 3 h. The DA was repeated at the same dose after pretreatment with ethinyl oestradiol (E<jats:sub>2<\/jats:sub>) 100 \u03bcg daily by mouth for 3 d, and after a further 2 week interval, following pretreatment with tamoxifen (TAM) 20 mg twice a day by mouth for 3 d. Ethinyl oestradiol pretreatment stimulated a rise in basal PRL levels in all subjects (mean \u00b1 SE, mU\/1; 2903 \u00b1 761 vs 2293 \u00b1 684, <jats:italic>P<\/jats:italic>&gt;0\u00b705) while TAM produced a higher but more variable increase in basal PRL levels (mean \u00b1 SE, mU\/1; 3402 \u00b1 757, <jats:italic>P<\/jats:italic>= n.s.). The individual increments in basal PRL levels after both E<jats:sub>2<\/jats:sub> and TAM pretreatment showed a significant positive correlation with the greater decrement in PRL levels during E<jats:sub>2<\/jats:sub> and TAM primed DA infusions (E<jats:sub>2<\/jats:sub>, <jats:italic>r<\/jats:italic>= 0\u00b793, <jats:italic>P<\/jats:italic> &gt; 0\u00b701, TAM, <jats:italic>r<\/jats:italic>= 0\u00b783, <jats:italic>P<\/jats:italic> &gt; 0\u00b705). E<jats:sub>2<\/jats:sub> pretreatment produced a rise in basal LH levels in 5\/7 patients, and there was a significant positive correlation between the rise in basal LH levels after E<jats:sub>2<\/jats:sub> and the decremental change in LH levels in E<jats:sub>2<\/jats:sub> primed DA infusions (<jats:italic>r<\/jats:italic>= 0\u00b794, <jats:italic>P<\/jats:italic>&gt;0\u00b701). Basal TSH levels were unaffected by E<jats:sub>2<\/jats:sub> and TAM pretreatment, but during DA infusion there was a significantly greater decremental change following E<jats:sub>2<\/jats:sub> pretreatment (sum of decrements, mean \u00b1 SE mU\/1; 8\u00b71 \u00b1 1\u00b758 vs 4\u00b765 \u00b1 1\u00b723, <jats:italic>P<\/jats:italic> &gt; 0\u00b702). In conclusion, E<jats:sub>2<\/jats:sub> and TAM increased PRL sensitivity to the inhibitory actions of DA treatment. In contrast, E<jats:sub>2<\/jats:sub> but not TAM, exerted similar effects on the dopaminergic inhibition of LH and TSH.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1985.tb00208.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T12:35:29Z","timestamp":1205757329000},"page":"139-146","source":"Crossref","is-referenced-by-count":3,"title":["THE INFLUENCE OF OESTROGENS ON THE SENSITIVITY OF PRL, TSH AND LH TO THE INHIBITORY ACTIONS OF DOPAMINE IN HYPERPROLACTINAEMIC PATIENTS"],"prefix":"10.1111","volume":"23","author":[{"given":"R.","family":"VALCAVI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. E.","family":"HARRIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"FOORD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"DIEGUEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"EVANS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"PETERS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"HALL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F.","family":"SCANLON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-45-1-65"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1983.tb02883.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91841-5"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-106-3-702"},{"key":"e_1_2_1_6_1","unstructured":"Elli R. Scaperotta R. C. Travaglini P. Beck\u2010Peccoz P.&Faglia G.(1983)Dopaminergic control of PRL TSH and LH secretion in tumoral hyperprolactinaemia.3rd International Workshop on Pituitary Adenomas Amsterdam p.6 (Abstract)."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-112-5-1567"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-54-2-404"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(83)90057-4"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-47-3-494"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-49-2-182"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.12.5946"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0580227"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1983.tb03191.x"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-108-2-489"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-48-4-718"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(15)33237-3"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.418505"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-5-975"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1979.tb03028.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350424"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1981.tb00608.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.1983.03330400050024","article-title":"Oral contraceptive use and the occurrence of pituitary prolactinoma","volume":"249","author":"Shy K. K.","year":"1983","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_1_24_1","first-page":"491","article-title":"Impaired pituitary response to bromocriptine suppression: reversal after bromocriptine plus tamoxifen","volume":"101","author":"Volker W.","year":"1982","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107600"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1985.tb00208.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1985.tb00208.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T06:59:32Z","timestamp":1697785172000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1985.tb00208.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,8]]}},"alternative-id":["10.1111\/j.1365-2265.1985.tb00208.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1985.tb00208.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,8]]}}}